Status:
COMPLETED
The Impact of Eyelid Hygiene on Ocular Surface
Lead Sponsor:
Saglik Bilimleri Universitesi
Conditions:
Dry Eye
Eligibility:
All Genders
18-50 years
Phase:
NA
Brief Summary
Dry eye is one of the most common eye diseases and it is known to be an ever-increasing public health problem in risky groups. Physical conditions (heat, light, humidity,ventilation), anesthetic gases...
Detailed Description
Dry eye disease is one of the most common pathologies of the ocular surface which is characterized by tear film instability due to insufficient tear production or increased evaporation. Its prevalence...
Eligibility Criteria
Inclusion
- Actively working in the operating room setting, aged ≤50 years, and having Stage ≥1 dry eye disease. In a clinical examination by the ophthalmologist, volunteers with TBUT \<10, Schirmer test \<5, OSDI score ≥ 13, MQ score\> 14.5, cornea or conjunctiva\> 1 staining and reporting at least one severe ocular symptom
Exclusion
- Active eye infection requiring treatment, receiving antihypertensives, antihistamines, psychogenic or chemotherapeutic agents, thyroid replacement therapy, or estrogen, having autoimmune diseases such as Sjögren's syndrome, rheumatoid arthritis, diabetes, or multiple sclerosis, having a previous anterior segment surgery, wearing contact lenses, receiving treatment for dry eye disease within the past six months, receiving omega-3 or vitamin A supplements currently or within the past three months, pregnant or lactating women, and menopausal or postmenopausal women
Key Trial Info
Start Date :
June 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2019
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04789824
Start Date
June 1 2018
End Date
September 1 2019
Last Update
March 10 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Aslı Nemli
Kayseri, Talas, Turkey (Türkiye), 35500
2
Erciyes Universitesi Hastanesi
Kayseri, Turkey (Türkiye)